[1] I. P. Santos, E. M. Barroso, T. C. B. Schut, P. J. Caspers, C. G. van Lanschot, D.-H. Choi, M. F. van der Kamp, R. W. Smits, R. van Doorn, R. M. Verdijk et al., “Raman spectroscopy for cancer detection and cancer surgery guidance: Translation to the clinics," Analyst 142(17), 3025–3047 (2017).

[2] M. Jermyn, J. Mercier, K. Aubertin, J. Desroches, K. Urmey, J. Karamchandiani, E. Marple, M.-C. Guiot, F. Leblond, K. Petrecca, “Highly accurate detection of cancer in situ with intraoperative, labelfree, multimodal optical spectroscopy," Cancer Res. 77(14), 3942–3950 (2017).

[3] K. Awasthi, D. Moriya, T. Nakabayashi, L. Li, N. Ohta, “Sensitive detection of intracellular environment of normal and cancer cells by auto-fluorescence lifetime imaging," J. Photochem. Photobiol. B 165, 256–265 (2016).

[4] Y. Wang, C. Song, M. Wang, Y. Xie, L. Mi, G. Wang, “Rapid, label-free, and highly sensitive detection of cervical cancer with fluorescence lifetime imaging microscopy," IEEE. J. Sel. Topics Quantum Electron. 22(3), 228–234 (2016).

[5] S. M. Levchenko, A. Pliss, J. Qu, “Fluorescence lifetime imaging of fluorescent proteins as an effective quantitative tool for noninvasive study of intracellular processes," J. Innov. Opt. Heal. Sci. 11(1), 1730009 (2018).

[6] M. Wang, F. Tang, X. Pan, L. Yao, X. Wang, Y. Jing, J. Ma, G. Wang, L. Mi, “Rapid diagnosis and intraoperative margin assessment of human lung cancer with fluorescence lifetime imaging microscopy," BBA clinical 8, 7–13 (2017).

[7] Y. Jing, Y. Wang, X. Wang, C. Song, J. Ma, Y. Xie, Y. Fei, Q. Zhang, L. Mi, “Label-free imaging and spectroscopy for early detection of cervical cancer," J. Biophotonics 11(5), e201700245 (2018).

[8] Z. Wang, Y. Zheng, D. Zhao, Z. Zhao, L. Liu, A. Pliss, F. Zhu, J. Liu, J. Qu, P. Luan, “Applications of fluorescence lifetime imaging in clinical medicine," J. Innov. Opt. Heal. Sci. 11(1), 1830001 (2018).

[9] M. Monici, “Cell and tissue autofluorescence research and diagnostic applications," Biotechnology Annual Review Vol. 11, 227–256, Elsevier (2005).

[10] J. McAlpine, S. El Hallani, S. Lam, S. Kalloger, M. Luk, D. Huntsman, C. MacAulay, C. Gilks, D. Miller, P. Lane, “Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: A promising step towards screening and early detection," Gynecol. Oncol. 120(3), 385–392 (2011).

[11] L. Alchab, G. Dupuis, C. Balleyguier, M.-C. Mathieu, M.-P. Fontaine-Aupart, R. Farcy, “Towards an optical biopsy for the diagnosis of breast cancer in vivo by endogenous fluorescence spectroscopy," J. Biophotonics 3(5–6), pp. 373–384 (2010).

[12] A. Dravid, N. Mazumder, “Types of advanced optical microscopy techniques for breast cancer research: A review," Laser. Med. Sci. 33(9), 1849–1858 (2018).

[13] H. Wallrabe, Z. Svindrych, S. R. Alam, K. H. Siller, T. Wang, D. Kashatus, S. Hu, A. Periasamy, “Segmented cell analyses to measure redox states of autofluorescent NAD (P) H, FAD & Trp in cancer cells by FLIM," Sci. Rep. 8(1), 79 (2018).

[14] T. S. Blacker, Z. F. Mann, J. E. Gale, M. Ziegler, A. J. Bain, G. Szabadkai, M. R. Duchen, “Separating NADH and NADPH fluorescence in live cells and tissues using FLIM," Nat. Commun. 5, 3936 (2014).

[15] T. S. Blacker, M. R. Duchen, “Investigating mitochondrial redox state using NADH and NADPH autofluorescence," Free Radical Bio. Med. 100, 53–65 (2016).

[16] J. A. Jo, S. Cheng, R. Cuenca-Martinez, E. Duran- Sierra, B. Malik, B. Ahmed, K. Maitland, Y.-S. L. Cheng, J. Wright, T. Reese, “Endogenous for early detection of oral cancer and dysplasia," in 2018 40th Annual Int. Conf. IEEE Engineering in Medicine and Biology Society (EMBC), pp. 3009–3012, IEEE (2018).

[17] J. E. Phipps, D. Gorpas, J. Unger, M. Darrow, R. J. Bold, L. Marcu, “Automated detection of breast cancer in resected specimens with fluorescence lifetime imaging," Phys. Med. Biol. 63(1), 015003 (2017).

[18] J. H. Segars, A. Al-Hendy, “Uterine leiomyoma: New perspectives on an old disease," in Seminars in reproductive medicine, pp. 471–472, Thieme Medical Publishers (2017).

[19] Q. Li, Y. Ding, X.-Y. Zhang, W.-W. Feng, K.-Q. Hua, “Drug therapy for adenomyosis: A prospective, nonrandomized, parallel-controlled study," J. Int. Med. Res. 46(5), 1855–1865 (2018).

[20] F. Taran, E. A. Stewart, S. Brucker, “Adenomyosis: Epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy," Geburtsh. Frauenheilk. 73(9), 924–931 (2013).

[21] M. Dueholm, “Minimally invasive treatment of adenomyosis," Best Pract. Res. Cl. Ob. 51, 119–137 (2018).

[22] J.-L. Brun, A. Cortez, R. Rouzier, P. Callard, M. Bazot, S. Uzan, E. Darai, “Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors," Am. J. Obstet. Gynecol. 199(3), 244.e1–244.e7 (2008).

[23] M. Zanello, F. Poulon, J. Pallud, P. Varlet, H. Hamzeh, G. A. Lahoud, F. Andreiuolo, A. Ibrahim, M. Pages, F. Chretien et al., “Multimodal optical analysis discriminates freshly extracted human sample of gliomas, metastases and meningiomas from their appropriate controls," Sci. Rep. 7, 41724 (2017).

[24] M. Zanello, F. Poulon, P. Varlet, F. Chretien, F. Andreiuolo, M. Pages, A. Ibrahim, J. Pallud, E. Dezamis, G. Abi-Lahoud et al., “Multimodal optical analysis of meningioma and comparison with histopathology," J. Biophotonoics 10(2), 253–263 (2017).

[25] F. Poulon, M. Zanello, A. Ibrahim, A. Zaylaa, P. Varlet, B. Devaux, D. A. Haidar, “Comparison between fresh and ˉxed human biopsies using spectral and lifetime measurements: Fluorescence analysis using one and two photon excitations," in 2015 Int. Conf. Advances in Biomedical Engineering (ICABME), pp. 25–28, IEEE (2015).

[26] X. Wang, Y. Xie, M. Huang, L. Yao, Y. Wang, Y. Fei, J. Ma, L. Mi, “Effect of ˉxation and mounting on fluorescence lifetime of cellular auto- fluorescence," IEEE J. Sel. Top. Quant. 25(1), 1–6 (2019).

[27] H. Schneckenburger, M. H. Gschwend, W. S. Strauss, R. Sailer, M. Kron, U. Steeb, R. Steiner, “Energy transfer spectroscopy for measuring mitochondrial metabolism in living cells," Photochem. Photobiol. 66(1), 34–41 (1997).

[28] J. Vergen, C. Hecht, L. V. Zholudeva, M. M. Marquardt, R. Hallworth, M. G. Nichols, “Metabolic imaging using two-photon excited NADH intensity and fluorescence lifetime imaging," Microsc. Microanal. 18(4), 761–770 (2012).

[29] A. Visser, A. v. Hoek, “The fluorescence decay of reduced nicotinamides in aqueous solution after excitation with a UV-mode locked Ar ion laser," Photochem. Photobiol. 33(1), 35–40 (1981).

[30] A. Uppal, P. K. Gupta, “Measurement of nadh concentration in normal and malignant human tissues from breast and oral cavity," Biotechnol. Appl. Biochem. 37(1), 45–50 (2003).

[31] K. Michalakis, G. Mintziori, A. Kaprara, B. C. Tarlatzis, D. G. Goulis, “The complex interaction between obesity, metabolic syndrome and reproductive axis: A narrative review," Metabolism 62(4), 457–478 (2013).

[32] J. Zicha, J. Kunes, M.-A. Devynck, “Abnormalities of membrane function and lipid metabolism in hypertension: A review," Am. J. Hypertens. 12(3), 315–331 (1999).